首页> 外国专利> SELECTIVE INHIBITION OF TLR4 SIGNALING

SELECTIVE INHIBITION OF TLR4 SIGNALING

机译:TLR4信号的选择性抑制

摘要

Blocking peptides comprised of the 14 amino acids that correspond to the sequences of the BB- loops of the four known TIR domain-containing adapter proteins (i.e. MyD88, TRAM, TIRAP, and TRIF) and homologous sequences of four TLRs (TLR2, TLR4, TLRl, and TLR6) are described. Adapter BB loop peptides disrupted TLR4, but not TLR2 signaling. TLR2 and TLR4 blocking peptides inhibited TLR4- and TLR2- mediated activation of ERK and cytokine induction, however, these peptides did not inhibit activation of p38. These peptides can be used to treat or prevent an immune or inflammatory response associated with a condition related to TLR4 signaling.
机译:封闭肽由14个氨基酸组成,分别对应于四个已知的含TIR结构域的衔接子蛋白(即MyD88,TRAM,TIRAP和TRIF)的BB-环序列和四个TLR(TLR2,TLR4,描述了TLR1和TLR6。衔接子BB环肽破坏TLR4,但不破坏TLR2信号传导。 TLR2和TLR4阻断肽抑制TLR4和TLR2介导的ERK激活和细胞因子诱导,但是,这些肽不抑制p38的激活。这些肽可用于治疗或预防与TLR4信号相关的疾病相关的免疫或炎症反应。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号